Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing precisely sumatriptan (as sumatriptan succinate) 100 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sumatriptan (substance) |
Inferred relationship |
Some |
|
Sumatriptan (as sumatriptan succinate) 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sumatriptan (substance) |
Inferred relationship |
Some |
|
sumatriptan 12 mg/mL, seringue préremplie de 0,5 mL d'une solution injectable |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sumatriptan (substance) |
Inferred relationship |
Some |
|
Product containing sumatriptan (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sumatriptan (substance) |
Inferred relationship |
Some |
1 |
Sumatriptan 20mg nasal spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sumatriptan (substance) |
Inferred relationship |
Some |
|
Sumatriptan 5mg nasal spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sumatriptan (substance) |
Inferred relationship |
Some |
|
Sumatriptan succinate 6mg injection solution 0.5mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sumatriptan (substance) |
Inferred relationship |
Some |
|
Sumatriptan succinate 12mg/mL injection solution 0.5mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sumatriptan (substance) |
Inferred relationship |
Some |
|
Sumatriptan succinate 25mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sumatriptan (substance) |
Inferred relationship |
Some |
|
Sumatriptan 10mg nasal spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sumatriptan (substance) |
Inferred relationship |
Some |
|
Sumatriptan succinate |
Is a |
False |
Sumatriptan (substance) |
Inferred relationship |
Some |
|
Sumatriptan 100mg rapid relase tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sumatriptan (substance) |
Inferred relationship |
Some |
|
Sumatriptan 50mg rapid release tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sumatriptan (substance) |
Inferred relationship |
Some |
|
Sumatriptan-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sumatriptan (substance) |
Inferred relationship |
Some |
1 |
Sumatriptan 6mg/0.5mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sumatriptan (substance) |
Inferred relationship |
Some |
|
Sumatriptan 4mg injection solution prefilled cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sumatriptan (substance) |
Inferred relationship |
Some |
|
Sumatriptan 6mg injection solution prefilled cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sumatriptan (substance) |
Inferred relationship |
Some |
|
Sumatriptan-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sumatriptan (substance) |
Inferred relationship |
Some |
1 |
Product containing naproxen sodium and sumatriptan |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sumatriptan (substance) |
Inferred relationship |
Some |
|
Sumatriptan-containing product in nasal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sumatriptan (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely sumatriptan (as sumatriptan succinate) 100 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Sumatriptan (substance) |
Inferred relationship |
Some |
1 |
Sumatriptan (as sumatriptan succinate) 50 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Sumatriptan (substance) |
Inferred relationship |
Some |
1 |
Product containing naproxen and sumatriptan (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sumatriptan (substance) |
Inferred relationship |
Some |
2 |
Naproxen- and sumatriptan-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sumatriptan (substance) |
Inferred relationship |
Some |
2 |
Sumatriptan succinate |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Sumatriptan (substance) |
Inferred relationship |
Some |
|
Product containing only naproxen and sumatriptan (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sumatriptan (substance) |
Inferred relationship |
Some |
2 |
Sumatriptan only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sumatriptan (substance) |
Inferred relationship |
Some |
1 |
Naproxen and sumatriptan only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sumatriptan (substance) |
Inferred relationship |
Some |
2 |
Product containing only sumatriptan in nasal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sumatriptan (substance) |
Inferred relationship |
Some |
1 |
Product containing only sumatriptan in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sumatriptan (substance) |
Inferred relationship |
Some |
1 |
Product containing only sumatriptan in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sumatriptan (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely sumatriptan 10 milligram/1 actuation conventional release nasal spray (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Sumatriptan (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely sumatriptan 10 milligram/1 actuation conventional release nasal spray (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Sumatriptan (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely sumatriptan 20 milligram/1 actuation conventional release nasal spray (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Sumatriptan (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely sumatriptan 20 milligram/1 actuation conventional release nasal spray (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Sumatriptan (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely sumatriptan 5 milligram/1 actuation conventional release nasal spray (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Sumatriptan (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely sumatriptan 5 milligram/1 actuation conventional release nasal spray (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Sumatriptan (substance) |
Inferred relationship |
Some |
1 |
Sumatriptan hemisulfate |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Sumatriptan (substance) |
Inferred relationship |
Some |
|